10Jul
Proactive Due Diligence Considerations for Life Sciences Dealmakers
In today’s competitive and fast-paced life sciences dealmaking environment, buyers and investors are often unable to spend as much time on due diligence as they might like. Market players are often highly focused on the science itself and, as a...
By:
McDermott Will & Emery
Related
New law passed on the adaptation of German data protection law to the GDPR - Following the amendmen...
Read More >
On June 24, 2019, the United States Supreme Court decided Dutra Group v. Batterton, No. 18-266, hold...
Read More >
On July 3, 2020, the U.S. Department of Justice (“DOJ”) and the U.S. Securities and Exchange Commi...
Read More >
For those of us who remember the Chernobyl nuclear disaster, HBO’s recent miniseries of the same na...
Read More >
On February 11, 2020, the Equal Employment Opportunity Commission (EEOC) filed a complaint in Connec...
Read More >
When you’re trying to buy a product or service, many times you’re being oversold things that you d...
Read More >